
Stansberry Investor Hour Don't Underestimate the Power of 'Hidden Compounders'
Apr 1, 2025
John Barr, managing director and portfolio manager at Needham Funds, practices long-term small- and mid-cap growth investing focused on 'hidden to quality compounders.' He discusses the four criteria he uses to find hidden compounders. He explains why family-run and niche businesses appeal, walks through case studies like LeMaitre and Oil-Dri, and shares when to hold or sell through big drawdowns.
AI Snips
Chapters
Books
Transcript
Episode notes
Hidden To Quality Compounders
- John Barr looks for "hidden to quality compounders": small companies with an existing business that are investing in a new growth initiative.
- He buys them when small, holds through the transition, and keeps them long after they become established quality compounders.
Four Criteria For Finding Hidden Compounders
- Use four screening criteria for hidden compounders: established business plus a misunderstood new investment, great management, margin-of-safety valuation, and a large addressable market.
- Barr prioritizes founders/family/long-tenured managers and looks for valuations that provide downside protection.
LeMaitre Vascular Turned A Small IPO Into A 32x Win
- LeMaitre Vascular (LMAT) was bought in 2008 as a small-cap niche vascular-device maker and became a 32x winner for the fund.
- The company scaled via many niche product launches and benefited from founder-family leadership and regulatory barriers.




